Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosis.

ABSTRACT:

Background and aims

Lipoprotein(a) [Lp(a)] is causally associated with aortic valve stenosis (AS) but Lp(a) testing among AS patients is not broadly incorporated into clinical practice. We evaluated trends in Lp(a) testing in an academic medical center.

Methods

Educational efforts and adding Lp(a) to the lipid panel on the electronic medical record (EMR) and pre-procedure order sets were used to increase awareness of Lp(a) as a risk factor in AS. Medical records at University of California San Diego Health (UCSDH) were analyzed from 2010 to 2020 to define the yearly frequency of first time Lp(a) testing in patients with diagnosis codes for AS or undergoing transcatheter aortic valve replacement (TAVR).

Results

Lp(a) testing for any indication increased over 5-fold fro

SUBMITTER: Bhatia HS 

PROVIDER: S-EPMC9674369 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature